Biomedical researchers engaged in gene therapy science depend on adeno-associated viruses (AAVs) to deliver a specific gene of interest into cells and animal models. However, consistency, scalability, and cost-effectiveness of this fundamental technique remain challenging, particularly as investigative therapies progress from research to clinical and commercial manufacturing stages.
Download this webinar from Thermo Fisher Scientific to learn how the latest AAV production system simplifies workflows and maximizes titers and reliability.
